Do you think you are overweight because you are lazy?
Do you think diabetes is just bad luck?
History tells a different story.
In 1967, a secret transaction took place that changed the health of the entire world.
Three Harvard scientists accepted a bribe of $6,500 (about $50,000 today) from the sugar industry.
Their mission?
To write a lie: “Fat causes heart disease. Sugar is safe.”
That single lie sparked the global obesity crisis and paved the way for today’s trillion-dollar weight loss drug market.
🍬 Detective’s Briefing: Project 226
- The Bribe: The Sugar Research Foundation (SRF) paid Harvard researchers to publish a review in the NEJM that demonized fat and exonerated sugar. This became **Project 226**.
- The Consequence: The “Low Fat” craze of the 1980s led food companies to replace fat with massive amounts of sugar and High Fructose Corn Syrup (HFCS). Obesity rates tripled.
- The Winner: Big Pharma. The problem created by the sugar lobby is now being “solved” by Eli Lilly and Novo Nordisk via monthly subscriptions to Ozempic and Zepbound.
This is not a conspiracy theory. These documents were uncovered by researchers at UCSF in 2016. In this file, we connect the dots between a $6,500 bribe and the new Ozempic economy.
The Bribe: Project 226 (1967)
In the 1960s, the sugar industry was panicked. Studies were beginning to show a link between sugar consumption and heart disease.
John Hickson, a top sugar executive, had an idea.
He paid three prestigious Harvard nutritionists—including Mark Hegsted, who later became the head of nutrition at the USDA—to shift the blame.
The deal was simple: Blame Saturated Fat. Ignore Sugar.
The resulting study was published in the New England Journal of Medicine. It worked perfectly. For the next 50 years, health guidelines told us to stop eating butter and steak, and start eating “Low Fat” yogurt (loaded with sugar).
The Low Fat Trap: The Bliss Point
In 1980, the US government officially recommended a “Low Fat” diet. It was a disaster.
The Taste Problem
When you remove fat from food, it tastes like cardboard. To fix this, food giants added the cheapest, most addictive ingredient they could find: Sugar and High Fructose Corn Syrup.
The Explosion
Look at the data. The moment the “Low Fat” guidelines were introduced, obesity and diabetes rates went vertical.
The Subscription Economy: Paying for the Cure
The food industry created the disease. Now, the pharmaceutical industry is selling the cure.
Enter GLP-1 agonists (Ozempic, Wegovy, Zepbound).
These drugs are miraculous. They stop the “food noise” in your brain.
But there is a catch: The Subscription Model.
If you stop taking the drug, the weight comes back. This means patients are effectively signing up for a lifetime subscription to their own body, costing $1,000 a month. It is the ultimate recurring revenue model.
The Detective’s Verdict: Don’t Get Mad, Get Rich
As a citizen, you should be angry. A $6,500 bribe destroyed the health of millions.
But as an investor, you must look at the reality.
The “Ozempic Economy” is here to stay. Goldman Sachs predicts this market will reach $100 billion by 2030.
📊 The Duopoly of Health
| Ticker | Company | The Logic |
|---|---|---|
| $LLY | Eli Lilly | Owner of Zepbound/Mounjaro. They are becoming the “Apple” of biotech. |
| $NVO | Novo Nordisk | Owner of Ozempic/Wegovy. The first mover in the weight loss revolution. |
THE CYCLE OF PROFIT
Big Sugar made us sick. Big Pharma makes us well (for a fee).
The best revenge is not just eating healthy, but owning the companies that profit from the solution.